RAD50 and breast neoplasm: In a cohort of 1809 breast tumours (cohort 1), low RAD50 mRNA was significantly associated with poor survival in the whole cohort (p = 0.00061, Fig. 3a) and ER− cohort (p = 0.011, Fig. 3c).